Navigation Links
Serigne Gueye Ndiaye Comments on New Sunscreen Labeling
Date:6/18/2013

San Francisco, California (PRWEB) June 18, 2013

Serigne Gueye Ndiaye, who practices dermatology in San Francisco, California, is issuing comment on a new article that explains the changing rules regarding sunscreen. Starting this summer, sunscreen brands found on store shelves will need to meet new labeling requirements from the Food and Drug Administration. These new rules were created to help clear up consumer misconceptions regarding proper usage and effectiveness of sunscreen.

With the new labeling laws, sunscreen that has an SPF of 15 or lower must come with a warning label that states it will not protect against skin cancer. Products can no longer claim that they are waterproof, only water-resistant. There is also some debate about whether sunscreens with SPF’s that are higher than 50 should even remain on the market, since it is not completely clear whether these products are actually more effective. There is also concern that consumers may be lulled into a false sense of security by the high SPF on the bottle, thus avoiding reapplying the product regularly.

The changes come partially as a response to ever increasing skin cancer rates, even as sunscreen sales bring in $1B each year. Melanoma diagnoses have steadily climbed nearly two percent since 2000, and are becoming frighteningly common among young, white women.

Some experts attribute this to improper use of sunscreen, where people either apply too little or fail to reapply the substance every two hours as advised. There is also concern that many sunscreens protect users from ultraviolet B rays, but do not necessarily also offer protection from ultraviolet A rays. These are the rays that are known to cause skin damage and aging, and are also linked with skin cancer.

Serigne Gueye Ndiaye comments on this issuing stating, “Even with the new changes to sunscreen labels, it is important that a person knows how to use the substance to receive adequate protection. Many people falsely believe that they can just slap a dollop on and receive protection all day. This is a dangerous misconception.”

Dr. Steven Q. Wang, director of dermatologic surgery and dermatology at Memorial Sloan-Kettering Cancer Center, comments on sunscreen use explaining, “Sunscreen is not a magic bullet. It’s just one of the defenses against the harmful effect of UV radiation, and that message gets lost.”

Recently, advocates have criticized the FDA for proposing ideas and then stepping away from them. Some of these plans have included putting a system in place that provides users with more information about the differences between UVA and UVA protection, capping the SPF levels on the market at 50, and banning sunscreen sprays, which are found to be less effective than lotions.

Serigne Gueye Ndiaye advises individuals to use sunscreen, but notes that they should also learn about other ways to protect themselves from the sun’s harsh rays.

ABOUT:

Serigne Gueye Ndiaye is a board-certified dermatologist who runs SGN Dermatology in San Francisco, California. At his practice, Ndiaye treats acne, eczema, psoriasis, and a number of other skin conditions. He also diagnoses and treats skin cancer. Serigne Gueye Ndiaye values sharing information with his patients about how they can protect their skin and keep it looking its best.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10842724.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications
2. Merrill DataSite Releases New Comments: Cash Reserves and M&A Options
3. Rottenstein Law Group LLP Comments on Drugmakers’ Cooperation With Safety Review of Byetta, Januvia, Victoza
4. Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Comments on Report Detailing Wright Hip Replacement Lawsuits, Other Metal-on-Metal Hip Claims
5. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Intuitive Surgical’s Decision to Replace Defective da Vinci Surgical Instrument
6. DePuy ASR Hip Recall: Bernstein Liebhard LLP Comments on DePuy’s Motion to Strike Costs in Wake of $8.25 Million DePuy ASR Lawsuit Judgment
7. Dr. Anthony Schepsis Comments on New ACL Repair Strategy
8. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
9. Mesh Lawsuit News: Bernstein Liebhard LLP Comments on Study to Investigate Safety, Benefits of Boston Scientific Mesh
10. Attorney Article Comments on 401(k) Fees Documentary, "The Retirement Gamble"
11. Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Comments on Ongoing Biomet M2a Magnum Hip Replacement Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... First Choice Emergency Room , ... Howard Ng, as the new Medical Director of its Pflugerville- FM 685 facility. ... Director of our Pflugerville- FM 685 location,” said Dr. Stephen Van Roekel, Reginal Medical ...
(Date:9/19/2017)... ... 2017 , ... The Davidson Institute for Talent Development will ... 27 at a reception in Washington D.C. The recipients received $50,000, $25,000 and ... “I am honored to be a Davidson Fellow Laureate,” said Rishab Gargeya, a ...
(Date:9/19/2017)... ... 19, 2017 , ... MarkeTouch Media has partnered with fred’s ... a modern design with a more streamlined user experience and is designed to ... app includes hundreds of digital coupons that can be clipped to a customer’s ...
(Date:9/18/2017)... ... , ... TransLuma is a set of dissolving transitions created for use within Final Cut ... luminance of a scene without the use of keyframes. Choose to bleed away ... , TransLuma allows editors to gradually dissolve away the light in a scene to reveal ...
(Date:9/18/2017)... ... , ... A September 7 article on BBC News describes new ... world’s most common and least expensive medications, may be able to stimulate stem cells ... California Dental Group and Calabasas Dental Care says that, while it’s likely to be ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... , Sept. 1, 2017 Michael ... Solutions, Inc , highlights opportunities for growth in his ... report that Marlin Equity is seeking a buyer for ... annual award-winning 22-year-old healthcare solutions Value Added Reseller and ... "As the healthcare market ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/29/2017)... ivWatch, LLC, the leading provider of continuous monitoring devices for the ... an Innovative Technology contract from Vizient, Inc., the largest member-driven health ... ... detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ivWatch based on ...
Breaking Medicine Technology: